FOLLICULAR MUCINOSIS CASE IN PATIENT WITH ATOPIC DERMATITIS
DOI:
https://doi.org/10.32782/2226-2008-2024-5-13Keywords:
follicular mucinosis, mucin, atopic dermatitisAbstract
Follicular mucinosis (scleromyxoedema) is a rare skin disease characterized by follicular degeneration due to the accumulation of mucin in the pilosebaceous unit accompanied with inflammatory changes. The purpose is to evaluate risk factors for the likelihood of secondary follicular mucinosis. Materials and methods. Cytomorphology of the patient’s skin samples (stains were used: hematoxylin-eosin, toluidine blue, Van Gieson’s picrofuchsin). Results. An observation of a clinical case of secondary follicular mucinosis of the skin, formed against the background of atopic dermatitis and the use of fillers with hyaluronic acid, is presented. The skin lesions of a 33-year-old female patient demonstrate clear clinical and histological features of follicular mucinosis. In the absence of standardized methods for treating this nosology, successful pathogenetic therapy was carried out: dapsone, tacrolimus, phototherapy (UVB 311nm), which led to almost complete regression of the pathological process. Conclusions. Timely diagnosis, pathogenetic treatment and control of the main disease reduce the risk of skin mucinosis recurrence and improve its long-term prognosis.
References
Mickel M, Jalili A, Gesslbauer C, Crevenna R. Implementation and evaluation of a rehabilitation concept in a patient suffering from Scleredema Adultorum Buschke: a case report. Disabil Rehabil. 2018; 40: 2833–2835. https://doi.org/10.1080/09638288.2017.1355939.
Fernandez-Flores A., Saeb-Lima M. Mucin as a diagnostic clue in dermatopathology. Journal of Cutaneous Pathology. 2016; 43(11): 1005–1016. https://doi.org/10.1111/cup.12782.
Shayegi N, Alakel N, Middeke JM, Schetelig J, Mantovani-Löffler L, Bornhäuser M. Allogeneic stem cell transplantation for the treatment of refractory scleromyxedema. Transl Res. 2015; 165(2): 321–324. https://doi.org: 10.1016/j.trsl.2014.06.002.
Cárdenas-Gonzalez R, Ruelas M, Candiani J. Lichen myxedematosus: a rare group of cutaneous mucinosis. Anais Brasileiros De Dermatologia. 2019; 94(4): 462–469. http://dx.doi.org/10.1590/abd1806-4841.20198478.
Kalli F, Cioni M, Parodi A, et al. Increased frequency of interleukin-4 and reduced frequency of interferon-γ and IL-17-producing CD4+ and CD8+ cells in scleromyxedema. J Eur Acad Dermatol Venereol. 2020; 34(5): 1092–1097. https://doi.org/ 10.1111/jdv.16136.
Vieyra-Garcia PA, Wolf P. A deep dive into UV-based phototherapy: mechanisms of action and emerging molecular targets in inflammation and cancer. Pharmacol Ther. 2021; 222: 107784. https://doi.org/10.1016/j.pharmthera.2020.107784.
Oh SJ, Oh SH, Jun JY, et al. Paraneoplastic atypical scleromyxedema with advanced gastric cancer. JAAD Case Rep. 2017; 3(5): 376–378. doi: 10.1016/j.jdcr.2017.04.005.
Ferreli C, Gasparini G, Parodi A, Cozzani E, Rongioletti F, Atzori L. Cutaneous manifestations of scleroderma and scleroderma-like disorders: a comprehensive review. Clin Rev Allergy Immunol. 2017; 53(3): 306–336. https://doi.org/ 10.1007/с12016-017-8625-4.
Mahévas T, Arnulf B, Bouaziz JD, et al. Plasma cell-directed therapies in monoclonal gammopathy-associated scleromyxedema. Blood. 2020; 135(14): 1101–1110. https://DOI10.1182/blood.2019002300.
Giavedoni P, Pousa-Martínez M, Estany-Destal A, Ginarte M, Vázquez-Veiga HTL, Mascaró JM. Usefulness of highfrequency Doppler ultrasound skin thickness measurement for disease staging and assessing treatment response in patients with scleredema: a case-control study. J Am Acad Dermatol. 2022; 86(1): 189–191. https://doi.org/10.1016/j.jaad.2021.01.050.
Perel-Winkler A, Derk C. Diffuse Cutaneous Mucinosis in Dermatomyositis: A Case Report and Review of the Literature. Case Reports іn Dermatological Medicine. 2014; 1: 1–6. https://doi.org/10.1155/2014/938414.
Shekari A, Ghiasi M, Ghasemi E, Kani Z. Papulonodular mucinosis indicating systemic lupus erythematosus. Clinical аnd Experimental Dermatology. 2009; 34(8): 558–560. https://doi.org/10.1111/j.1365-2230.2009.03235.x.
Mecoli CA, Talbot CC Jr, Fava A, et al. Clinical and molecular phenotyping in scleromyxedema pretreatment and posttreatment with intravenous immunoglobulin. Arthritis Care Res. 2020; 72(6): 761–767. https://doi.org/10.1002/acr.23908.
Tani N, Sugita K, Yamamoto O. Paclitaxel-related scleredema-like skin changes in a patient with breast cancer. Australas J Dermatol. 2018; 59(3): e215–e217. http://doi:10.1111/ajd.12719.
Muñoz-Aceituno E, Vega González R, Martínez Palazuelos M, Pérez Gala S, Llamas-Velasco M, Fraga J, Dauden E. Association between eosinophilic folliculitis and follicular mucinosis. A case series. International Journal оf Dermatology. 2020; 59(10): 376–378. https://doi.org/10.1111/ijd.14890.
